XL413

• Description:

  XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  289.06

• Molecular Formula:

  C14H12ClN3O2

• Notes:

  Research use only, not for human use.

• Receptor:

  Cdc7

• CAS Number:

  1169558-38-6